InsidersTradesSigma
중앙백신 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 중앙백신 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 중앙백신 has logged 19 insider filings. Market capitalisation: €90.8bn. The latest transaction was disclosed on 29 April 2026 (Purchase). Among the most active insiders: 중앙백신. All data is accessible without an account.
19
Insider Decl.
0
Thresholds
€250,922
2 ops.
Buy Volume
·
4 ops.
Sell Volume
32Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,153 of 26,212 companies
67.0
score / 100
Value69
Quality65
FCF yld2.2%
Earn yld7.1%
EV/EBITDA7.1x
ROE3.8%
Gross mgn49%
Net mgn13%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 April 2026
Declarations19 total
19 of 19 declarations